Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Lee

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The American Journal of Managed Care|February 26, 2011
Resource utilization with insulin pump therapy for type 2 diabetes mellitusPeter M Lynch, Aylin Altan Riedel, Navendu Samant, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|August 27, 2005
Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot studyDavid Kelvin Bland, Yvonne Fankhanel, Eileen Langford, et al.
Diabetes Technology & Therapeutics|April 25, 2014
Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensorTimothy S Bailey, Andrew Ahmann, Ronald Brazg, et al.
Diabetes Technology & Therapeutics|November 18, 2017
The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed<sup>™</sup> 670G Hybrid Closed-Loop SystemToni L Cordero, Satish K Garg, Ronald Brazg, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2018
IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELSRobert A Vigersky, Suiying Huang, Toni L Cordero, et al.
Diabetes Technology & Therapeutics|January 23, 2014
The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exerciseThomas Danne, Christiana Tsioli, Olga Kordonouri, et al.
Diabetes, Obesity & Metabolism|April 5, 2017
Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trialMuriel Metzger, Javier Castañeda, Yves Reznik, et al.
Journal of Diabetes Science and Technology|August 6, 2013
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemiaDavid C Klonoff, Richard M Bergenstal, Satish K Garg, et al.
Diabetes Technology & Therapeutics|December 8, 2011
Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithmsDesmond Barry Keenan, John Joseph Mastrototaro, Howard Zisser, et al.
Journal of Diabetes Science and Technology|January 10, 2012
The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemiaRonald L Brazg, Timothy S Bailey, Satish Garg, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The American Journal of Managed Care|February 26, 2011
Resource utilization with insulin pump therapy for type 2 diabetes mellitusPeter M Lynch, Aylin Altan Riedel, Navendu Samant, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|August 27, 2005
Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot studyDavid Kelvin Bland, Yvonne Fankhanel, Eileen Langford, et al.
Diabetes Technology & Therapeutics|April 25, 2014
Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensorTimothy S Bailey, Andrew Ahmann, Ronald Brazg, et al.
Diabetes Technology & Therapeutics|November 18, 2017
The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed<sup>™</sup> 670G Hybrid Closed-Loop SystemToni L Cordero, Satish K Garg, Ronald Brazg, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2018
IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELSRobert A Vigersky, Suiying Huang, Toni L Cordero, et al.
Diabetes Technology & Therapeutics|January 23, 2014
The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exerciseThomas Danne, Christiana Tsioli, Olga Kordonouri, et al.
Diabetes, Obesity & Metabolism|April 5, 2017
Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trialMuriel Metzger, Javier Castañeda, Yves Reznik, et al.
Journal of Diabetes Science and Technology|August 6, 2013
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemiaDavid C Klonoff, Richard M Bergenstal, Satish K Garg, et al.
Diabetes Technology & Therapeutics|December 8, 2011
Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithmsDesmond Barry Keenan, John Joseph Mastrototaro, Howard Zisser, et al.
Journal of Diabetes Science and Technology|January 10, 2012
The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemiaRonald L Brazg, Timothy S Bailey, Satish Garg, et al.
Pageof 4